Residual Solvents & Impurities: What Else Can Be In There
When peptides are made, organic solvents and other residues can stay in the powder. These are checked with special methods like gas chromatography, and the limits are set by the ICH Q3C guideline. A single purity number says nothing about this.
What are residual solvents in peptides and how do they form?
Residual solvents are volatile chemicals that can stay behind in the finished powder as residues during peptide production. In solid-phase peptide synthesis (SPPS) - the step-by-step assembly on a solid resin - large amounts of substances like dimethylformamide (DMF), dichloromethane (DCM), or acetonitrile are used. The later purification via high-performance liquid chromatography (HPLC) can also leave traces of these solvents in the final product.
The ICH Q3C guideline sets international limits for residual solvents in pharmaceuticals. It sorts solvents into three classes: Class 1 (to be avoided, e.g., benzene), Class 2 (to be limited, e.g., DMF), and Class 3 (low toxic potential). These limits are meant to protect patients, but they officially apply to pharmaceutical products; whether they also apply to unregulated peptides is not documented.
Analysis methods: How are residual solvent tests performed?
Gas chromatography with headspace sampling (GC-HS) is the most common way to detect volatile residues. Here, the sample is heated to analyze the vapor above the powder - the so-called headspace - without the peptide clogging the measuring column. To identify unknown substances, the method is often combined with mass spectrometry (GC-MS).
The test follows standardized protocols such as the USP method <467>. This method can detect very low concentrations - benzene, for example, down to 0.5 ppm (parts per million). A test result shows whether the specifically targeted solvents are below the set limits. However, the finding applies only to the specific sample tested and the substances examined in that instance.
Other impurities: Deletion sequences and TFA residues
Besides residual solvents, other residues such as deletion or truncation sequences can form during peptide synthesis. These incomplete peptide chains arise when individual amino acids are not attached correctly. By-products like diketopiperazines are also possible. Since these impurities are chemically very similar to the target peptide, they are hard to separate completely during purification.
Another common residue is trifluoroacetic acid (TFA), which serves as an auxiliary agent in cleaving from the resin and in purification. Peptides therefore often exist as TFA salts, which can interfere with analysis and require separate quantification via ion chromatography. Other reagents from the synthesis can also leave traces, although the data on this is often incomplete.
Why the purity claim (HPLC) does not capture residual solvents
A purity claim of "98%" is usually based on an HPLC measurement of UV absorption, which does not detect volatile solvents. Since substances like DMF or DCM, as well as TFA salts, barely absorb UV light, they are not captured by this standard method. Additionally, some impurities can elute together with the target peptide, falsely inflating the purity number.
The purity number alone therefore does not give a complete picture of product quality, as it excludes residual solvents and the TFA content. To get a full picture, complementary methods such as GC-MS or ion chromatography are necessary. These methods are not interchangeable but meaningfully supplement the HPLC analysis.
What the findings mean: What a residual solvent test proves
A positive result below the limits confirms that the tested solvents are not present in the sample in amounts that are a health concern. This information is valuable, but it has limits: The result only refers to the tested sample. Whether other samples from the same batch are similar is not automatically proven. Stability over time or uniformity within a batch are also separate questions.
Moreover, standard tests only cover the solvents listed in the guideline; for unexpected substances, a specific GC-MS analysis is required. Since a residual solvent test does not provide information about non-volatile residues like deletion sequences or TFA content, each finding remains an important piece of the puzzle, but not a comprehensive overall certificate.
Sources
- ICH Q3C (R9) Residual solvents - Scientific guideline | European Medicines Agency (EMA)
- Optimization of the Water-Insoluble Procedures for USP General Chapter Residual Solvents <467>
- Total wash elimination for solid phase peptide synthesis - PMC - NIH
- Towards a Consensus for the Analysis and Exchange of TFA ...
- The Role of Counter-Ions in Peptides—An Overview - PMC
- Q3C (R8) Step 5 - impurities: guideline for residual solvents - EMA
- Elimination and exchange of trifluoroacetate counter-ion from cationic peptides: a critical evaluation of different approaches
- ICH Q3C (R9) Guideline on impurities - EMA
- HPLC Analysis and Purification of Peptides - PMC
- Q3C(R8) Impurities: Guidance for Residual Solvents
- Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives - PubMed
- Mechanistic Study of Diketopiperazine Formation during Solid-Phase Peptide Synthesis of Tirzepatide
- Residual Solvent Testing in United States: USP & FDA ...
- Improvement of Analysis and Transferability in Peptide Purification: From HPLC to FPLC and Back Again - PMC
- Q3C(R8) Impurities: Guidance for Residual Solvents ...
- Chromatoprobe as a sample-sparing technique for residual solvent analysis of drug discovery candidates by gas chromatography
- Guideline on the Development and Manufacture of Synthetic Peptides
- 5015.8 Acceptance Criteria for Residual Solvents
- Elemental Impurities (ICH Q3D) and Residual Solvents (ICH Q3C) Testing for Synthetic Peptide APIs
- Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation
- Impurities: Guideline for Residual Solvents Q3C(R8)
- Solvents for Solid Phase Peptide Stynthesis Contents | AAPPTec
- Evaluation of greener solvents for solid-phase peptide synthesis
- Residual Solvent Testing – USP & ICH Q3C- GC-FID and GC-MS